Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen
HIA is a cooperative research cluster under RWTH Aachen University uniting seven biomedical engineering institutes across four faculties. It conducts interdisciplinary R&D in medical devices, biomaterials, molecular imaging, and stem cell biology, partnering with University Hospital Aachen for clinical translation.
- Company typePrivate
- Founded1971
- HeadquartersAachen, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen does
The Helmholtz-Institute for Biomedical Engineering (HIA) is a cooperative research cluster (Arbeitsgemeinschaft) operating under RWTH Aachen University, a public law corporation (Körperschaft des öffentlichen Rechts) in North Rhine-Westphalia, Germany. The legal name is "Helmholtz-Institut für Biomedizinische Technik der RWTH Aachen University," founded in 1971 under sponsorship of Forschungsgesellschaft für Biomedizinische Technik e.V. Aachen following a Volkswagenwerk Foundation call for tenders. HIA was fundamentally restructured in 2001 when it was formally integrated into RWTH Aachen University through a cooperation agreement across four participating faculties. The institute unites seven institutes from four faculties (Medicine, Mechanical Engineering, Electrical Engineering and Information Technology, Mathematics and Natural Sciences) and is co-located with the University Hospital Aachen for clinical translation. HIA marked its 50th anniversary with a one-day symposium on 28 June 2024.
HIA's research portfolio is organized around seven chairs and research areas including Applied Medical Engineering (AME, encompassing biohybrid medical textiles, cardiovascular engineering, computational mechanics, and neuromechanics/assistive robotics); Medical Information Technology (MedIT, focused on closed-loop therapy devices, biomechatronics, bioimpedance spectroscopy/EIT, wearables, intelligent textiles, and contactless measurement with signal processing/AI); Medical Engineering (mediTEC, covering biomechanical modeling/simulation, image-guided surgery, mechatronics, robotics, ultrasound/shockwaves); Biomaterials (glycobiotechnology, polymeric building blocks for soft 3D biomaterials); Experimental Molecular Imaging (ExMI, nanoparticles for cancer radio-immunotherapy and theranostics); Stem Cell Biology; and the Biointerface Laboratory (cell and molecular biology at interfaces). Notable research outputs include sensor-free contactless monitoring systems for premature infants, biohybrid implants for cardiovascular and respiratory systems, AI-based signal processing for wearable medical devices, and image-/model-guided surgical technology.
HIA does not operate a commercial business model. As a public university research institute, its activities are funded through public research grants, third-party funding (Drittmittel), and institutional support from RWTH Aachen University, with revenue not publicly disclosed. HIA does not produce commercial products, charge customers, or offer APIs or SDKs. It serves three primary constituencies: the University Hospital Aachen as clinical translation partner, the medical technology industry for collaborative research and technology transfer (including an annual excursion partnership with B. Braun Melsungen), and students/researchers participating in cross-faculty biomedical engineering education. Distribution occurs through academic publications, the biennial Helmholtz Symposium Aachen, the regular BMT-Kolloquium seminar series, annual research reports, GDPR/BITV-compliant web dissemination, and direct technology-transfer collaborations with industry and international partners such as KTH Royal Institute of Technology Stockholm.
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen firmographics
Firmographics- Name
- Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen
- Legal name
- Helmholtz-Institut für Biomedizinische Technik der RWTH Aachen University
- Website
- https://hia.rwth-aachen.de
- Company type
- Private
- Founded year
- 1971
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- HIA is a cooperative research cluster under RWTH Aachen University uniting seven biomedical engineering institutes across four faculties. It conducts interdisciplinary R&D in medical devices, biomaterials, molecular imaging, and stem cell biology, partnering with University Hospital Aachen for clinical translation.
- Ownership category
- akta.pro rank
Where Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen is headquartered
LocationHeadquarters
- HQ city
- Aachen
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Distribution channels1 record
Marketing channels6 records
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen product offering
Product offeringCore offering
The Helmholtz-Institute for Biomedical Engineering (HIA) is a cooperative research cluster comprising seven institutes from four faculties of RWTH Aachen University and the University Hospital Aachen. It conducts interdisciplinary basic and application-oriented research in biomedical engineering — spanning medical technology, information technology, biomaterials, molecular imaging, and stem cell biology — aimed at improving patient diagnosis, therapy, and rehabilitation. It also coordinates cross-faculty teaching and runs academic events such as the Helmholtz Symposium Aachen and the BME-Colloquium.
Product overview
The Helmholtz-Institute for Biomedical Engineering (HIA) is a cooperative research cluster comprising seven chairs and research areas from four faculties of RWTH Aachen University and University Hospital Aachen. The institute focuses on interdisciplinary biomedical engineering research and education rather than commercial product development. Its portfolio includes research chairs in Medical Information Technology (MedIT) focused on wearable medical devices and closed-loop therapy systems; Medical Engineering (mediTEC) focused on biomechanical simulation and surgical robotics; Applied Medical Engineering (AME) focused on biohybrid medical textiles and cardiovascular engineering; Biomaterials focused on glycobiotechnology; Experimental Molecular Imaging (ExMI) focused on nanomedicines for cancer therapy; plus Stem Cell Biology and Biointerface Laboratory at the University Hospital. The institute also organizes the biennial Helmholtz Symposium Aachen and regular BMT-Kolloquium events for academic exchange.
Differentiator
Problem solved
Functional benefit
Products and services
- Chair for Medical Information Technology (MedIT)
Quantifiable outcome
- Development of sensor-free monitoring systems for premature infants
- +2 more outcomes
Companies that use Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen
Customer profileSegments3 records
Ideal customer profiles3 records
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature7 records
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- RWTH Aachen University (Faculty of Medicine)coreIntegration into RWTH Aachen University in 2001 with the Faculty of Medicine taking over the institute; establishment of the Helmholtz-Institute for Biomedical Engineering Work Community through cooperation agreement between Medical Faculty, Faculty of Electrical Engineering and Information Technology, Faculty of Mechanical Engineering, and Faculty of Mathematics, Computer Science and Natural Sciences.
- University Hospital Aachen (UK Aachen)coreClose partnership with University Hospital Aachen for clinical translation of biomedical engineering research; hosts several HIA institutes including Institute for Applied Medical Engineering, Institute for Experimental Molecular Imaging, Institute for Stem Cell Biology, and Institute for Cell and Molecular Biology at Interfaces.
- KTH Royal Institute of Technology StockholmminorResearch collaboration through Digital Futures Excellence Cluster; Prof. Steffen Leonhardt conducting three-month research stay at KTH Stockholm, hosted by Prof. Seraina Dual in Technology and Health Division near Karolinska Institut.
- B. Braun MelsungenminorAnnual Pentecost excursion to B. Braun facilities providing insights into medical device manufacturing including dialysis equipment and sterilization processes; exchange between science and industry through lectures and plant tours.
- Faculty of Electrical Engineering and Information Technology (RWTH)coreCooperation partner hosting the Chair for Medical Information Technology (MedIT) and contributing to interdisciplinary biomedical engineering research within HIA.
- Faculty of Mechanical Engineering (RWTH)coreCooperation partner hosting the Chair for Medical Engineering (mediTEC) and contributing to interdisciplinary biomedical engineering research within HIA.
- Faculty of Mathematics, Computer Science and Natural Sciences (RWTH)coreCooperation partner hosting the Teaching and Research Area for Biomaterials and contributing to interdisciplinary biomedical engineering research within HIA.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen competitors and assessment
Company assessmentBroad incumbents
- Case Western Reserve University Department of Biomedical Engineering: Long-standing US biomedical engineering department known for biomaterials, medical devices and clinical translation — peer in mission and translational posture to HIA.
- ETH Zurich – Department of Health Sciences and Technology: Large European university department combining biomedical engineering, materials, imaging and clinical translation — a natural academic peer to HIA's cross-faculty biomedical engineering model.
- Johns Hopkins Department of Biomedical Engineering: Top US biomedical engineering department with strong medical device, imaging and tissue engineering programs — comparable in research breadth and clinical integration to HIA.
- Imperial College London – Department of Bioengineering: Leading European biomedical engineering department with strong biomaterials, bioimaging, and medical device work — directly comparable to HIA in research scope and academic structure.
- Fraunhofer Institute for Digital Medicine MEVIS: German applied-research institute focused on medical image computing, AI for diagnostics, and clinically translatable software — directly comparable to HIA's experimental molecular imaging and medical information technology workstreams.
- Helmholtz Zentrum München – Institute for Biomedical Engineering: Another Helmholtz-associated biomedical engineering/molecular imaging research hub in Germany; comparable as a German public research consortium translating engineering into clinical and biological applications.
- MIT Institute for Medical Engineering and Science (IMES): Cross-faculty medical engineering institute bridging engineering and medicine at MIT; analogous mission and cross-disciplinary structure to HIA's Arbeitsgemeinschaft model.
Regional players
- Karolinska Institutet – Department of Medical Engineering: Sweden's medical university with strong translational medical technology work; HIA has an active research collaboration with KTH Stockholm hosted near Karolinska, making it a relevant international peer.
- Leibniz Institute for Interactive Materials (DWI): Aachen-based materials research institute with biomedical applications; geographically co-located peer working on biomaterials adjacent to HIA's glycobiotechnology work.
Direct peers
- TU Munich – Institute of Medical Engineering (IMETUM): German technical university's interdisciplinary medical engineering institute combining mechanics, electronics and clinical applications — the closest domestic structural peer to HIA.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen social profiles
Digital presenceHelmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen compliance and trust
Trust signalCompliance4 records
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen financial estimates
Financial estimateRevenue estimate
Valuation estimate
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen leadership team
Management profileNumber of profiles
Profiles8 records
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen
What does Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen do?
The Helmholtz-Institute for Biomedical Engineering (HIA) is a cooperative research cluster comprising seven institutes from four faculties of RWTH Aachen University and the University Hospital Aachen. It conducts interdisciplinary basic and application-oriented research in biomedical engineering — spanning medical technology, information technology, biomaterials, molecular imaging, and stem cell biology — aimed at improving patient diagnosis, therapy, and rehabilitation. It also coordinates cross-faculty teaching and runs academic events such as the Helmholtz Symposium Aachen and the BME-Colloquium.
Is Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen a public or private company?
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen is a private company. It is classified as state government owned and is currently operating.
When was Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen founded?
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen was founded in 1971. It employs 11 to 50 people.
Where is Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen based?
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen is headquartered in Aachen, Germany, in the Europe region.
Who are Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen's main competitors?
Broad incumbents on record are Case Western Reserve University Department of Biomedical Engineering, ETH Zurich – Department of Health Sciences and Technology, Johns Hopkins Department of Biomedical Engineering, Imperial College London – Department of Bioengineering, Fraunhofer Institute for Digital Medicine MEVIS, Helmholtz Zentrum München – Institute for Biomedical Engineering and MIT Institute for Medical Engineering and Science (IMES). Regional players are Karolinska Institutet – Department of Medical Engineering and Leibniz Institute for Interactive Materials (DWI). TU Munich – Institute of Medical Engineering (IMETUM) is listed as a direct peer.
Does Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen have an API?
No public API is recorded for Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen.